The High Cost of Survival: A Young Boy’s Battle with Treatment-Induced Leukemia and the Quest for Pediatric Oncology Innovation
admin In May 2025, a seven-year-old boy named Lincoln sat down with his father, Jay, for...
admin
Spring Into Action for Pediatric Cancer Research Community Initiatives and Sports Partnerships Drive New Funding for Lifesaving Clinical Trials
The arrival of the spring season has historically served as a catalyst for renewed philanthropic...
A New Era in Cancer Care: Immunotherapy Summit Unveils Breakthroughs from Long-Term Survival to AI-Driven Cures
The IO360° Summit, held in Boston in February 2026, served as a pivotal gathering for...
Johnson & Johnson Exceeds Q1 Expectations with Robust Oncology Growth, Navigating Immunology Shifts
Johnson & Johnson, the global healthcare behemoth, announced a stellar first-quarter performance for 2026, significantly...
White House Proclaims September 2025 as Childhood Cancer Awareness Month and Outlines Comprehensive Make America Healthy Again Strategy
The White House officially designated September 2025 as Childhood Cancer Awareness Month, signaling a reinforced...
Bold and Unstoppable: Glamorama Ambassador Valerie’s Story
In a quiet bedroom, 10-year-old Valerie keeps a piece of artwork that serves as a...
CureSearch for Children’s Cancer Appoints LiveRamp Chief Procurement Officer Mark Zafra to Board of Directors
CureSearch for Children’s Cancer, a leading national non-profit organization dedicated to accelerating the development of...
Immunotherapy Revolutionizes Kidney Cancer Treatment, Offering Renewed Hope and Extended Lives for Patients
A kidney cancer diagnosis often ushers in a period of profound uncertainty, fear, and a...
Filspari’s Clearance in FSGS Marks End of Winding Regulatory Journey and Unlocks Over $1 Billion Annual Revenue Opportunity
The recent clearance of Filspari (sparsentan) by the U.S. Food and Drug Administration (FDA) for...
Haven’s Journey: Navigating a B-Cell Acute Lymphoblastic Leukemia Diagnosis and the Intersection of Trisomy 21
The intersection of pre-existing genetic conditions and pediatric oncology presents a complex set of challenges...
